Clinical Research Infrastructure in Mexico

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Clinical Research Infrastructure in Mexico

Clinical Research Infrastructure in Mexico – CRO Mexico

Clinical research plays a pivotal role in advancing medical knowledge, improving healthcare outcomes, and fostering the development of innovative therapies. Mexico, a country with a rich cultural heritage and a rapidly growing economy, is increasingly recognized as a promising hub for clinical research.

With its diverse patient population, robust healthcare system, and evolving regulatory framework, Mexico has the potential to contribute significantly to global clinical trials. In this blog post, we will explore the current state of clinical research infrastructure in Mexico, highlighting key initiatives, challenges, and opportunities for further growth.

Overview of Clinical Research Infrastructure


Mexico’s clinical research infrastructure comprises a network of healthcare institutions, research centers, and regulatory bodies that facilitate the conduct of clinical trials. The National Institutes of Health in Mexico (NIH-Mexico) and the Mexican Ministry of Health (MoH) are key stakeholders involved in shaping the clinical research landscape.


These organizations collaborate with academic institutions, hospitals, and pharmaceutical companies to support the development and execution of clinical trials.


Regulatory Framework and Ethical Considerations


Mexico has made significant strides in aligning its regulatory framework with international standards. The Federal Commission for the Protection against Sanitary Risk (COFEPRIS) is the regulatory authority responsible for approving and overseeing clinical trials.


COFEPRIS has implemented regulations that adhere to Good Clinical Practice (GCP) guidelines and ensure the ethical conduct of research involving human subjects. The National Bioethics Committee provides oversight and guidance on ethical considerations.



Advantages of Conducting Clinical Trials in Mexico (approx. 200 words): Mexico offers several advantages for conducting clinical trials. Firstly, the country boasts a diverse population with varying genetic backgrounds and disease prevalence, which facilitates more comprehensive data collection and generalizability of study results.


Secondly, Mexico’s healthcare system comprises public and private institutions, providing a broad patient pool for recruitment. Additionally, the relatively lower costs of conducting clinical trials in Mexico compared to developed nations make it an attractive destination for sponsors and investigators.


Moreover, Mexico’s geographic proximity to the United States allows for efficient collaboration with international partners.


Clinical Research Infrastructure in Mexico

Clinical Research Infrastructure in Mexico

Clinical Research Infrastructure in Mexico

Challenges and Opportunities


While Mexico has made significant progress, it faces certain challenges in optimizing its clinical research infrastructure. These challenges include limited awareness among healthcare professionals and patients regarding clinical trial opportunities, inadequate research funding, and bureaucratic hurdles in the regulatory approval process.


Overcoming these obstacles requires collaborative efforts among stakeholders, including government bodies, research institutions, and industry partners.

To capitalize on its potential, Mexico can seize various opportunities for growth. Strengthening educational programs to train healthcare professionals in clinical research methodologies and ethics will enhance the quality of studies conducted in the country.

Additionally, increasing public awareness about the importance of clinical trials and the potential benefits to patients can contribute to higher participation rates. Furthermore, fostering international collaborations and attracting more global pharmaceutical companies to conduct trials in Mexico can boost research investment and knowledge exchange.


Mexico’s clinical research infrastructure has made significant progress in recent years, positioning the country as an emerging destination for clinical trials. With a solid regulatory framework, a diverse patient population, and promising opportunities for growth, Mexico has the potential to contribute substantially to medical advancements globally.

Addressing the existing challenges and capitalizing on the identified opportunities will be key to further enhancing the country’s clinical research capabilities.

By investing in infrastructure, education, and collaborative efforts, Mexico can foster a thriving clinical research ecosystem that improves patient outcomes, accelerates medical discoveries, and strengthens its position as a vital player in the global healthcare landscape.

Clinical Research Infrastructure in Mexico

Source: Roche

Clinical Research Infrastructure in Mexico

Cohortias the CRO of LATAM

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Clinical Research Infrastructure in Mexico

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Clinical Research Infrastructure in Mexico

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Clinical Research Infrastructure in Mexico

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Clinical Research Infrastructure in Mexico

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Clinical Research Infrastructure in Mexico

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Clinical Research Infrastructure in Mexico

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Clinical Research Infrastructure in Mexico

The Cohortias Team

Clinical Research Infrastructure in Mexico

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Clinical Research Infrastructure in Mexico

Network & Partnerships